Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632509 · ClinicalTrials.gov registry record
BD SiteRite(TM) 9 Ultrasound System - Clinical Study
A clinical trial, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 149
- Enrollment target
NCT06632509 is a clinical trial that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 149 participants.
The verdict
NCT06632509 has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
This post-market study is being conducted to generate safety and performance data on the SiteRite 9 System. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.
Interventions
- DEVICE BD SiteRite(TM) 9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2026-01-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06632509
The ClinicalTrials.gov registry entry for NCT06632509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BD SiteRite(TM) 9 is the first listed.
NCT06632509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06632509 about?
NCT06632509 is a clinical study titled "BD SiteRite(TM) 9 Ultrasound System - Clinical Study". This post-market study is being conducted to generate safety and performance data on the SiteRite 9 System. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.
What is the current status of trial NCT06632509?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2025-11-12. Estimated completion is 2026-01-09.
What interventions are being tested in trial NCT06632509?
The interventions under investigation include: BD SiteRite(TM) 9 (DEVICE).
Who is sponsoring clinical trial NCT06632509?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.